- Home
- LXRX vs REFI Comparison
LXRX vs REFI Comparison
Compare LXRX & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- REFI
- Stock Information
- Founded
- LXRX 1995
- REFI 2021
- Country
- LXRX United States
- REFI United States
- Employees
- LXRX N/A
- REFI N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- REFI Real Estate Investment Trusts
- Sector
- LXRX Health Care
- REFI Real Estate
- Exchange
- LXRX Nasdaq
- REFI Nasdaq
- Market Cap
- LXRX 283.7M
- REFI 314.2M
- IPO Year
- LXRX 2000
- REFI 2021
- Fundamental
- Price
- LXRX $0.71
- REFI $15.55
- Analyst Decision
- LXRX Buy
- REFI Strong Buy
- Analyst Count
- LXRX 2
- REFI 3
- Target Price
- LXRX $4.00
- REFI $20.00
- AVG Volume (30 Days)
- LXRX 4.1M
- REFI 120.3K
- Earning Date
- LXRX 03-10-2025
- REFI 03-11-2025
- Dividend Yield
- LXRX N/A
- REFI 16.35%
- EPS Growth
- LXRX N/A
- REFI N/A
- EPS
- LXRX N/A
- REFI 2.00
- Revenue
- LXRX $5,229,000.00
- REFI $56,860,278.00
- Revenue This Year
- LXRX $842.94
- REFI N/A
- Revenue Next Year
- LXRX $19.76
- REFI $6.40
- P/E Ratio
- LXRX N/A
- REFI $7.95
- Revenue Growth
- LXRX 886.60
- REFI 6.49
- 52 Week Low
- LXRX $0.62
- REFI $14.82
- 52 Week High
- LXRX $2.83
- REFI $16.49
- Technical
- Relative Strength Index (RSI)
- LXRX 43.33
- REFI 46.54
- Support Level
- LXRX $0.66
- REFI $15.93
- Resistance Level
- LXRX $0.97
- REFI $16.07
- Average True Range (ATR)
- LXRX 0.07
- REFI 0.21
- MACD
- LXRX -0.00
- REFI 0.04
- Stochastic Oscillator
- LXRX 16.13
- REFI 43.48
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.